OPEN END TURBO LONG - ELANCO ANIMAL HEALTH Stock

Certificat

DE000MB6P8B5

Delayed Börse Stuttgart 04:58:50 2024-07-12 am EDT
0.49 EUR 0.00% Intraday chart for OPEN END TURBO LONG - ELANCO ANIMAL HEALTH
Current month-15.52%
1 month-47.31%
Date Price Change
24-07-12 0.49 0.00%
24-07-11 0.49 +6.52%
24-07-10 0.46 -6.12%
24-07-09 0.49 -7.55%
24-07-08 0.53 -3.64%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 04:58 am EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ELANCO ANIMAL HEALTH INCORPORATED
Issuer Morgan Stanley
WKN MB6P8B
ISINDE000MB6P8B5
Date issued 2023-05-29
Strike 8.383 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.07
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.94
Lowest since issue 0.061
Spread 0.03
Spread %5.77%

Company Profile

Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Sector
-
More about the company

Ratings for Elanco Animal Health Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Elanco Animal Health Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
13.67 USD
Average target price
19.3 USD
Spread / Average Target
+41.16%
Consensus